Industry / India
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Looking Abroad For Growth
December 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
As domestic competition intensifies, two of India's leading drugmakers are targeting both emerging and developed market for future growth opportunities. Cadila Healthcare and Aurobindo Pharma are respectively looking to boost sales by 50% in 2-3 years and become a billion-dollar company by 2009-10. Given the cost advantages of predominantly operating in India, BMI is fairly confident that both companies will achieve their